Biohaven Total Stockholder Equity vs Other Stockholder Equity Analysis
| BHVN Stock | USD 38.45 1.37 3.69% |
Biohaven Pharmaceutical financial indicator trend analysis is way more than just evaluating Biohaven Pharmaceutical prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biohaven Pharmaceutical is a good investment. Please check the relationship between Biohaven Pharmaceutical Total Stockholder Equity and its Other Stockholder Equity accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biohaven Pharmaceutical Holding. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
Total Stockholder Equity vs Other Stockholder Equity
Total Stockholder Equity vs Other Stockholder Equity Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biohaven Pharmaceutical Total Stockholder Equity account and Other Stockholder Equity. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Biohaven Pharmaceutical's Total Stockholder Equity and Other Stockholder Equity is -0.32. Overlapping area represents the amount of variation of Total Stockholder Equity that can explain the historical movement of Other Stockholder Equity in the same time period over historical financial statements of Biohaven Pharmaceutical Holding, assuming nothing else is changed. The correlation between historical values of Biohaven Pharmaceutical's Total Stockholder Equity and Other Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Stockholder Equity of Biohaven Pharmaceutical Holding are associated (or correlated) with its Other Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Stockholder Equity has no effect on the direction of Total Stockholder Equity i.e., Biohaven Pharmaceutical's Total Stockholder Equity and Other Stockholder Equity go up and down completely randomly.
Correlation Coefficient | -0.32 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.Other Stockholder Equity
Most indicators from Biohaven Pharmaceutical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biohaven Pharmaceutical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biohaven Pharmaceutical Holding. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. At this time, Biohaven Pharmaceutical's Selling General Administrative is very stable compared to the past year. As of the 17th of May 2024, Enterprise Value is likely to grow to about 3.2 B, though Tax Provision is likely to grow to (1.3 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Reconciled Depreciation | 1.4M | 1.4M | 6.9M | 7.3M | Cost Of Revenue | 91.7M | 1.4M | 3.4M | 3.2M |
Biohaven Pharmaceutical fundamental ratios Correlations
Click cells to compare fundamentals
Biohaven Pharmaceutical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Biohaven Pharmaceutical fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 344.3M | 111.5M | 142.1M | 661.8M | 513.2M | 347.2M | |
| Other Current Liab | 52.1M | 27.1M | 37.2M | 79.3M | 36.5M | 38.6M | |
| Total Current Liabilities | 66.2M | 29.9M | 41.9M | 90.0M | 55.4M | 49.1M | |
| Total Stockholder Equity | (7.4M) | 16.8M | 34.7M | 538.8M | 428.0M | 449.4M | |
| Property Plant And Equipment Net | 8.2M | 13.6M | 18.2M | 52.4M | 48.6M | 51.0M | |
| Net Debt | (316.7M) | 185.0M | 550.7M | (174.3M) | (218.8M) | (207.9M) | |
| Retained Earnings | (972.4M) | (1.7B) | (2.6B) | (91.1M) | (499.3M) | (524.3M) | |
| Accounts Payable | 14.1M | 2.8M | 4.8M | 10.7M | 15.6M | 10.0M | |
| Cash | 316.7M | 82.5M | 76.1M | 204.9M | 249.7M | 151.5M | |
| Non Current Assets Total | 16.0M | 21.7M | 47.2M | 74.8M | 70.8M | 40.6M | |
| Non Currrent Assets Other | 7.8M | 1.0M | 3.2M | 2.6M | 2.4M | 4.2M | |
| Cash And Short Term Investments | 316.7M | 82.5M | 76.1M | 465.3M | 383.1M | 270.2M | |
| Liabilities And Stockholders Equity | 344.3M | 111.5M | 142.1M | 661.8M | 513.2M | 347.2M | |
| Non Current Liabilities Total | 285.5M | 4.8M | 5.4M | 33.0M | 29.8M | 55.3M | |
| Other Current Assets | 11.6M | 10K | 2.1M | 19.3M | 45.7M | 47.9M | |
| Other Stockholder Equity | 83.5M | 98.9M | 169.7M | 13.9M | 39.8M | 73.8M | |
| Total Liab | 351.7M | 34.7M | 47.4M | 123.0M | 85.2M | 91.0M | |
| Total Current Assets | 328.3M | 89.8M | 94.8M | 587.0M | 442.4M | 306.6M | |
| Common Stock | 881.4M | 1.2B | 1.7B | 615.7M | 887.5M | 970.6M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biohaven Pharmaceutical Holding. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Complementary Tools for Biohaven Stock analysis
When running Biohaven Pharmaceutical's price analysis, check to measure Biohaven Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biohaven Pharmaceutical is operating at the current time. Most of Biohaven Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Biohaven Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biohaven Pharmaceutical's price. Additionally, you may evaluate how the addition of Biohaven Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |
Is Biohaven Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biohaven Pharmaceutical. If investors know Biohaven will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biohaven Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.90) | Return On Assets (0.65) | Return On Equity (1.34) |
The market value of Biohaven Pharmaceutical is measured differently than its book value, which is the value of Biohaven that is recorded on the company's balance sheet. Investors also form their own opinion of Biohaven Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Biohaven Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biohaven Pharmaceutical's market value can be influenced by many factors that don't directly affect Biohaven Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biohaven Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biohaven Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biohaven Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.